Omega Therapeutics, Inc. (OMGA) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 32 transactions totaling $76.7M, demonstrating a bullish sentiment with $75.8M in net insider flow. The most recent transaction on Jun 2, 2023 involved a sale of 5,000 shares valued at $40.0K.
No significant insider buying has been recorded for OMGA in the recent period.
No significant insider selling has been recorded for OMGA in the recent period.
Based on recent SEC filings, insider sentiment for OMGA is bullish with an Insider Alignment Score of 99/100 and a net flow of $75.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Omega Therapeutics, Inc. (OMGA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading OMGA stock, having executed 32 transactions in the past 90 days. The most active insider is Pioneering Inc. Flagship (Executive), who has made 11 transactions totaling $39.2M.
Get notified when executives and directors at OMGA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | A. Young Richard | Executive | Sale | 5,000 | $8.00 | $40.0K | |
| May 1, 2023 | A. Young Richard | Executive | Sale | 5,000 | $8.00 | $40.0K | 10b5-1 |
| Apr 6, 2023 | A. Young Richard | Executive | Sale | 5,000 | $8.00 | $40.0K | 10b5-1 |
| Mar 17, 2023 | A. Young Richard | Executive | Sale | 10,000 | $8.00 | $80.0K | |
| Feb 27, 2023 | Inc. Flagship Pioneering | Executive | Purchase | 1,993,986 | $5.78 | $11.5M | Large |
| Feb 27, 2023 | Inc. Flagship Pioneering | Executive | Purchase | 1,329,324 | $5.78 | $7.7M | Large |
| Jan 10, 2023 | A. Young Richard | Executive | Sale | 20,000 | $8.00 | $160.0K | |
| Sep 14, 2022 | A. Young Richard | Executive | Sale | 10,000 | $8.00 | $80.0K | |
| Feb 1, 2022 | Karande Mahesh | Executive | Option Exercise | 11,300 | $0.53 | $6.0K | |
| Aug 3, 2021 | Management S.a. Artal International | Executive | Conversion | 1,323,530 | $N/A | $0 | |
| Aug 3, 2021 | Management S.a. Artal International | Executive | Purchase | 875,000 | $17.00 | $14.9M | Large |
| Aug 3, 2021 | A. Berry David | Executive | Purchase | 53,082 | $17.00 | $902.4K | Large |
| Aug 3, 2021 | Sawhney Roger | Executive | Purchase | 2,941 | $17.00 | $50.0K | |
| Aug 3, 2021 | Fund Vi, L.p. Flagship Pioneering | Executive | Conversion | 970,588 | $N/A | $0 | |
| Aug 3, 2021 | Fund Vi, L.p. Flagship Pioneering | Executive | Conversion | 1,323,529 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $76.2M | 99.4% |
Sale(S) | 6 | $440.0K | 0.6% |
Exercise(M) | 1 | $6.0K | 0.0% |
Conversion(C) | 13 | $0 | 0.0% |
Insiders at Omega Therapeutics, Inc. are accumulating shares at an accelerated pace. With 7 insiders making 32 transactions totaling $76.2M in purchases versus $440.0K in sales, the net buying activity of $75.8M signals strong executive confidence. Pioneering Inc. Flagship (Executive) leads the buying activity with $39.2M in transactions across all time.